AMENDMENT NO. 1 TO THE COMMERCIAL SUPPLY AGREEMENT BETWEEN THERAPEUTICSMD, INC. AND CATALENT PHARMA SOLUTIONS, LLC (Estradiol and Progesterone softgel capsules)The Commercial Supply Agreement • November 9th, 2020 • TherapeuticsMD, Inc. • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 9th, 2020 Company Industry JurisdictionThis Amendment No. 1 (the "First Amendment") by and between THERAPEUTICSMD, INC. ("TXMD") and CATALENT PHARMA SOLUTIONS, LLC ("CATALENT"), to the Agreement (as defined below), is made as of this 1st day of December, 2017 (the "First Amendment Effective Date"). TXMD and CATALENT are sometimes herein referred to individually as a "Party" and collectively as the "Parties".